About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Exercise and Nutrition on Obese Microbiome | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT04138303

Exercise and Nutrition on Obese Microbiome

The purpose of this study is to examine the effects nine weeks of intense exercise training will have on weight, inflammation, and intestinal bacteria composition of overweight and obese adults.

Lead sponsor: University of Miami•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

University of Miami

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. Individuals who are overweight (BMI ≥ 25) and/or obese (BMI ≥ 30).
•2. Individuals who volunteer for the 54-day exercise program.
•3. Individuals with no history of diabetes mellitus (type I or II) or sickle cell disease.
•4. Individuals who are not taking antibiotics and have not taken antibiotics within 3 months.
•5. Individuals who are not taking probiotics.
•6. Individuals who are not taking Metformin.
•7. Individuals who are cleared by their physician to perform strenuous exercise.
•8. Individuals with no physically debilitating injuries that would keep them from being able to perform the exercises prescribed.
•9. Individuals who are between 18 and 60.

Related studies

Nutrition Care in Patients Living With Chronic Pain

NCT06277232 · Nutrition Poor, Overweight and Obesity, and more

The Effects of a 4-week Supplementation With a Ketogenic Nutrient Mix on 24-hour Substrate Metabolism and Muscle Health

NCT07395973 · Overweight and Obesity

RECRUITINGPhase 2/3

Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia

NCT05316493 · Atypical Endometrial Hyperplasia, Fertility Issues, and more

RECRUITINGPhase 2

Social Determinants and a Diabetes Prevention Program Tailored for African Americans

NCT05301413 · PreDiabetes, Overweight and Obesity

Becoming United in Lifestyle Decisions

NCT05796141 · Overweight and Obesity

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 7, 2020Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment31

Start dateOct 2019

Last updatedJan 7, 2020

Condition

Overweight and Obesity

Locations shown

University of Miami

Miami, Florida

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 7, 2020Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions